title: [18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
abstract: Congenital hyperinsulinism can be divided into diffuse or focal form. The treatment and outcome depend on distinguishing between the 2 forms. Pancreatic venous sampling was the only method available to localize the insulin secretion. [F]Fluoro-levodopa, 3,4-dihydroxy-L-phenylalanine positron emission tomography/computed tomography is a noninvasive imaging investigation and increasingly used to determine the type of hyperinsulinism preoperatively. We present a case of diffuse form of congenital hyperinsulinism demonstrated by the [F]levodopa, 3,4-dihydroxy-L-phenylalanine positron emission tomography/computed tomography preoperatively and review the literature.
authors: Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA. Subramaniam.rathan@mayo.edu
authors: Rathan M
authors: RM
authors: Subramaniam
authors: Dimitrios
authors: D
authors: Karantanis
authors: Patrick J
authors: PJ
authors: Peller
mesh_terms: D044903:Congenital Hyperinsulinism / Q000000981:diagnostic imaging*; D003937:Diagnosis, Differential; D004295:Dihydroxyphenylalanine / Q000031:analogs & derivatives*; D005260:Female; D005462:Fluorine Radioisotopes; D006801:Humans; D007223:Infant; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals; D014057:Tomography, X-Ray Computed
chemical_list: D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; C043437:fluorodopa F 18; D004295:Dihydroxyphenylalanine